Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Portland, ME
SEC filing record 1 source field available
Fiscal year end
31 December
IMMUCELL CORP /DE/ has filed 788 SEC EDGAR filings since 03 Aug 1995

SEC filing history

Showing 301-325 of 527 matching filings.

Per page
25
Current page
13
8-K File 001-12934

CURRENT REPORT

Filing date
14 Aug 2017
Reporting date
10 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-39373

SC 13DA

Filing date
31 Jul 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
28 Jul 2017
Reporting date
27 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
28 Jul 2017
Reporting date
27 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-12934

CURRENT REPORT

Filing date
27 Jul 2017
Reporting date
27 Jul 2017
Next action
Verify source filing
424B5 File 333-207635

PROSPECTUS SUPPLEMENT

Filing date
27 Jul 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-12934

CURRENT REPORT

Filing date
27 Jul 2017
Reporting date
27 Jul 2017
Next action
Verify source filing
8-K File 001-12934

CURRENT REPORT

Filing date
25 Jul 2017
Reporting date
24 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-12934

FORM 8-K

Filing date
14 Jul 2017
Reporting date
13 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-12934

CURRENT REPORT

Filing date
16 Jun 2017
Reporting date
16 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-12934

QUARTERLY REPORT

Filing date
11 May 2017
Reporting date
31 Mar 2017
Next action
Verify source filing
8-K File 001-12934

CURRENT REPORT

Filing date
11 May 2017
Reporting date
11 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-12934

DEFINITIVE PROXY STATEMENT

Filing date
28 Apr 2017
Reporting date
14 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-12934

ANNUAL REPORT

Filing date
30 Mar 2017
Reporting date
31 Dec 2016
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
21 Mar 2017
Reporting date
17 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
15 Mar 2017
Reporting date
13 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-12934

IMMUCELL CORPORATION 8-K

Filing date
08 Mar 2017
Reporting date
08 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-12934

IMMUCELL CORPORATION 8-K

Filing date
02 Mar 2017
Reporting date
02 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 Feb 2017
Reporting date
10 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 Feb 2017
Reporting date
10 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 Feb 2017
Reporting date
10 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 Feb 2017
Reporting date
10 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-12934

IMMUCELL CORPORATION 8-K

Filing date
10 Feb 2017
Reporting date
10 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-39373

NORTHPOINTE CAPITAL LLC

Filing date
25 Jan 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-214641

PROSPECTUS

Filing date
15 Dec 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .